• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲关于流感大流行规划的新视角,特别关注哺乳动物细胞培养疫苗的作用。

A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines.

作者信息

Oxford J S, Manuguerra C, Kistner O, Linde A, Kunze M, Lange W, Schweiger B, Spala G, Rebelo de Andrade H, Pérez Breña P R, Beytout J, Brydak L, Caraffa de Stefano D, Hungnes O, Kyncl J, Montomoli E, Gil de Miguel A, Vranckx R, Osterhaus A

机构信息

Centre for Infectious Diseases, Retroscreen Virology Ltd, Bart's and The London, Queen Mary's School of Medicine and Dentistry, 327 Mile End Road, London E1 4NS, UK.

出版信息

Vaccine. 2005 Nov 16;23(46-47):5440-9. doi: 10.1016/j.vaccine.2004.10.053.

DOI:10.1016/j.vaccine.2004.10.053
PMID:16168526
Abstract

Sixteen EU scientists and doctors were interviewed about pandemic planning using psychometric methods applied to a scientific problem for the first time. Criticism was aimed at countries which have no plan whatsoever, the majority of nations. Many such countries have not invested in scientific infrastructure and public health. Amongst the 15 or so published pandemic plans a lack of detail was identified. Of particular need was investment into avian virus vaccine stocks (H1-15), prepared licenses of vaccine and pre purchase and agreed distribution, investment into stocks of antivirals, antibiotics and masks. Most but not all members of the group predicted a global outbreak within 5 years, most probably starting in SE Asia. However it was recognised that a pandemic could start anywhere in the world which had juxtaposition of young people, chickens, ducks and pigs. Mammalian cell culture production using wild type virus with the production factory at category III levels of security was exemplified. Antivirals would be essential to ameliorate the first wave of infection although significant quantities of cell grown vaccine could be produced if, as in 1918, 1957 and 1968 there is a long period between the first virus isolation and person to person spread. The wider scientific community is more energised than previously for very serious preparations to be in place way before the outbreak begins as this is a major public health problem, completely dwarfing concerns about bioterrorism.

摘要

16位欧盟科学家和医生接受了访谈,此次访谈首次运用心理测量方法来探讨大流行规划这一科学问题。批评矛头指向了绝大多数没有任何计划的国家。许多这样的国家没有在科学基础设施和公共卫生方面进行投资。在已公布的约15份大流行计划中,发现存在缺乏细节的问题。特别需要投资于禽流感病毒疫苗储备(H1 - 15)、准备好疫苗许可证以及预购和商定好分配事宜,投资于抗病毒药物、抗生素和口罩储备。该小组的大多数成员(但并非全部)预测在5年内会出现全球大爆发,最有可能始于东南亚。然而,人们认识到,只要有年轻人、鸡、鸭和猪并存的地方,世界上任何地方都可能引发大流行。文中举例说明了利用野生型病毒在具有III级安全水平的生产工厂进行哺乳动物细胞培养生产的情况。抗病毒药物对于缓解第一波感染至关重要,不过,如果像1918年、1957年和1968年那样,在首次病毒分离和人际传播之间有很长一段时间,就可以生产出大量细胞培养疫苗。由于这是一个重大的公共卫生问题,远超对生物恐怖主义的担忧,广大科学界比以往更加积极地准备在疫情爆发前就做好充分准备。

相似文献

1
A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines.欧洲关于流感大流行规划的新视角,特别关注哺乳动物细胞培养疫苗的作用。
Vaccine. 2005 Nov 16;23(46-47):5440-9. doi: 10.1016/j.vaccine.2004.10.053.
2
[Influenza vaccine: globalization of public health stakes].[流感疫苗:公共卫生利益的全球化]
Med Trop (Mars). 2009 Aug;69(4):322.
3
Pandemic influenza: overview of vaccines and antiviral drugs.大流行性流感:疫苗与抗病毒药物概述
Yale J Biol Med. 2005 Oct;78(5):321-8.
4
Comparison of the content of the New Zealand influenza pandemic plan with European pandemic plans.新西兰流感大流行计划内容与欧洲大流行计划的比较。
N Z Med J. 2009 Feb 27;122(1290):36-46.
5
Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.季节性流感和2009年甲型H1N1流感大流行疫苗的生产能力。
Vaccine. 2009 Aug 20;27(38):5184-6. doi: 10.1016/j.vaccine.2009.06.034. Epub 2009 Jun 27.
6
[Recommendation of the Royal Academy for Medicine of Belgium to the responsible policy authorities in connection with the continually increasing threat of an outbreak of an influenza epidemic].[比利时皇家医学院就流感疫情爆发的持续威胁不断增加向相关政策当局提出的建议]
Verh K Acad Geneeskd Belg. 2006;68(2):139-50.
7
The pandemic threat: are we prepared?大流行威胁:我们做好准备了吗?
Issue Brief (Mass Health Policy Forum). 2006 Jun 8(29):1-14.
8
Seasonal and pandemic influenza: a 2007 update on challenges and solutions.季节性流感与大流行性流感:2007年挑战与解决方案最新情况
Clin Infect Dis. 2008 Apr 1;46(7):1024-31. doi: 10.1086/528720.
9
Pandemic influenza: imminent threat, preparedness and the divided globe.大流行性流感:紧迫威胁、防范措施与分裂的世界
Indian Pediatr. 2009 Feb;46(2):115-21.
10
Avian influenza pandemic threat and health systems response.禽流感大流行威胁与卫生系统应对措施。
Emerg Med Australas. 2006 Oct-Dec;18(5-6):430-43. doi: 10.1111/j.1742-6723.2006.00906.x.

引用本文的文献

1
Influenza A viruses: why focusing on M2e-based universal vaccines.甲型流感病毒:为何专注于基于M2e的通用疫苗。
Virus Genes. 2011 Feb;42(1):1-8. doi: 10.1007/s11262-010-0547-7. Epub 2010 Nov 17.
2
Vaccines for an influenza pandemic: scientific and political challenges.应对流感大流行的疫苗:科学与政治挑战
Influenza Other Respir Viruses. 2007 Mar;1(2):55-60. doi: 10.1111/j.1750-2659.2007.00011.x.
3
Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity.通过改变钠离子转运和蛋白激酶C活性来调节流感病毒复制。
Antiviral Res. 2008 Nov;80(2):124-34. doi: 10.1016/j.antiviral.2008.05.008. Epub 2008 Jun 13.
4
A quantitative risk assessment of exposure to adventitious agents in a cell culture-derived subunit influenza vaccine.细胞培养衍生亚单位流感疫苗中接触外来因子的定量风险评估。
Vaccine. 2008 Jun 19;26(26):3332-40. doi: 10.1016/j.vaccine.2008.03.075. Epub 2008 Apr 18.
5
MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells.与传统的MDCK细胞相比,MDCK-SIAT1细胞对近期人流感病毒的分离率更高。
J Clin Microbiol. 2008 Jul;46(7):2189-94. doi: 10.1128/JCM.00398-08. Epub 2008 May 14.
6
Development of stable influenza vaccine powder formulations: challenges and possibilities.稳定流感疫苗粉末制剂的研发:挑战与可能性
Pharm Res. 2008 Jun;25(6):1256-73. doi: 10.1007/s11095-008-9559-6.
7
Scientific barriers to developing vaccines against avian influenza viruses.开发抗禽流感病毒疫苗的科学障碍。
Nat Rev Immunol. 2007 Apr;7(4):267-78. doi: 10.1038/nri2054.